Page 2503 - Williams Hematology ( PDFDrive )
P. 2503

2474           Index                                                                                                                                                                                               Index         2475




               Oligoclonal immunoglobulins, 1725–1726  of the jaw, 1757                 p27 kip1 , 218
               Oligodendrocyte progenitor cells (OPCs),   Osteopenia, 771               p38 kinases, 298, 301f
                       452                          Osteopetrosis, 1091                 p40 phox  (NCF4), 1029
               Omacetaxine, 1458, 1466              Osteopontin, 64, 1846t              p47 phox  (NCF1), 1028t, 1029
               Omega-3-fatty acids                  Osteoporosis                        p53
                 for sickle cell disease, 777t        acute lymphoblastic leukemia treatment   apoptosis and, 208f, 209
                 for stroke prevention, 2297               and, 1520                      cancer and, 132, 195, 210, 238
               Omenn syndrome, 1166, 1219–1220        heparin-induced, 2277               in chronic myelogenous leukemia
               Omeprazole, megaloblastic anemia and, 605,   mast cell numbers and, 972         transformation, 1464
                       606t                           in mastocytosis, 977                functions, 195
               Oncogenes, 219. See also Chromosomal   in sickle cell disease, 771         vascular tone and, 2283
                       abnormalities; Gene mutations  Osteoprotegerin (OPG), 249, 1713, 1737,   p53
               Oncostatin M, 248, 933t, 1978               1738f, 1739f                   in diffuse large B-cell lymphoma, 1626
               One-compartment model, 430f          Osteosclerosis, 1325, 1330            in mantle cell lymphoma, 1654
               Onion extract, 2079                  Osteosclerotic myeloma (POEMS syndrome),   in myeloma, 1710
               OPCs (oligodendrocyte progenitor cells), 452  9, 1733, 1746              p55, 663t, 667, 667f
               Open canalicular system, 1835f, 1836  Ostwald viscosimeter, 506          p67 phox  (NCF2), 1028t, 1029
               OPG (osteoprotegerin), 249, 1713, 1737,   Ovalocytes. See Elliptocytes (ovalocytes)  p107, 217, 238
                       1738f, 1739f                 Ovary, primary lymphomas in, 1582   p130, 238
               Opioids, for sickle cell disease pain, 767–768  Owren parahemophilia, 1925  P140K-MGMT, 442, 443f
               Oprelvekin, 1358                     Oxidant damage, hemolysis and, 809–810  p190, 1442
               Oprozomib, for myeloma, 1753         2-Oxoglutarate (2OG, α-ketoglutarate), 169,   p205 radixin, 1006
               Opsonic receptors, 934t, 1054               193, 196                     p210 BCR-ABL , 1440–1441, 1442–1443
               Opsonins, 106, 284, 1017, 1054       Oxygen dissociation curve, 761      p230, 1442
               Opsonization, 1160                   Oxygen gas, hemolytic anemia and, 809–810  PA. See Pernicious anemia (PA)
               ORAI1 (Orai1), 1221, 1836            Oxygen transport                    PACAP, 2061
               Oral cavity, history of disorders of, 5  anemia and, 504–505, 504f, 505f  Pacific Biosciences real-time sequencing,
               Oral contraceptives                    hemoglobin and, 761                      158–159, 158f
                 venous thromboembolism risk and, 2226t,   hypervolemia and, 506, 510f  Paclitaxel, 326, 1631, 2297
                       2227                           in red cells in newborn, 104, 104f  PAD (peripheral arterial disease), 2297
                 for von Willebrand disease, 2176   Oxymetholone, for anemia of primary   PADGEM. See P-selectin
               Oral hairy leukoplakia, 1266                myelofibrosis, 1328          PAF. See Platelet-activating factor (PAF)
               Orbital adnexal lymphoma, 1571, 1579  Ozone, 809–810                     Pagetoid reticulosis, 1683
               Orbital compression syndrome, 772                                        PAI-1. See Plasminogen activator inhibitor
               Organic acids, in erythrocytes, 471t  P                                         (PAI)-1
               Organismal aging, 132                P1PK blood group/antigens, 2331t, 2334t,   Pain
               ORMDL3 (orosomucoid-like 3), 950            2337, 2339, 2340, 2344t        abdominal, history of, 5
               Ornithine decarboxylase (ODC), 200, 238  P2RY8, 1508                       bone, history of, 6
               Oropharynx, history of disorders of, 5  P2X , 1874, 2056–2057              chest, history of, 5
                                                       1
               Orosomucoid-like 3 (ORMDL3), 950     P2Y , 1874–1875                       shoulder, history of, 6
                                                       1
               Oroya fever (Bartonella infection), 818, 997  P2Y , 1874–1875, 2056–2057   in sickle cell disease, 767–768
                                                       12
               Orthochromic (orthochromatic)        P4P (polyphosphate-4-phosphatase), 1817  in tongue, history of, 5
                       erythroblasts, 34, 463f, 465, 465f  p14 ARF , 218, 238           Palbociclib, 215, 218
               Orthochromic normoblast, 463f        p15 (CDKN2B), 232t                  Palifermin, 368
               Orthopedic surgery, 2371             p16 (CDKN2), 232t, 236t, 1654, 1734  Pallor
               Oseltamivir, 386                     p16 (INK4A/ARF), 230t                 eyes, 8
               Osteoblasts, marrow, 35, 60          p16 INK4A , 214, 238                  history of, 6
               Osteoclasts                          p16 INK4A /cyclin D /cdk4/RB/E24 cascade, 215,   mouth, 8
                                                                1
                 deficiency, 1091                          217                            skin, 7
                 development, 1077, 1077f, 1078     p16 INK4A -RB pathway, 214, 225     Palpitations, history of, 5
                 markers, 1080t                     p16 INK4B , 218                     PALS (periarterial lymphoid sheath), 88, 89f,
                 marrow, 35, 60–61                  p16 INK4C , 218                            90f
               Osteogenesis imperfecta, 2061        p16 INK4D , 218                     Pamidronate, 1756
               Osteomyelitis, 771, 1513             p21 , 217–218, 225                  Pancreas, 452
                                                      cip1
               Osteonecrosis                        p22 phox  (CYBA), 1013t, 1027, 1028t, 1029  Pancreatic disease
                 in Gaucher disease, 1125f          P24. See CD9                          cobalamin deficiency and, 602








          Kaushansky_index_p2393-2506.indd   2474                                                                       9/21/15   3:22 PM
   2498   2499   2500   2501   2502   2503   2504   2505   2506   2507   2508